LabCorp expands availability of at-home sample collection kit for COVID-19 test
Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Ramakrishnan M. and Sriraj Kalluvila
(Reuters) – LabCorp said on Tuesday its at-home sample collection kit for COVID-19 testing would now be available to all individuals with symptoms and possible exposure to the virus, after limiting delivery to healthcare workers during its launch last month.
The collection kit, with a list price of $119, consists of cotton swabs to collect nasal specimens, a biohazard specimen bag and a FedEx overnight shipping envelope to mail the samples to labs.
Customers can get the kit with no upfront out-of-pocket costs if they are found to be eligible after filling in a survey on the company’s website, LabCorp said.
The company said it would submit the claim to the individual’s health insurance agency, or the appropriate government program, in case the person does not have insurance.